EXEL vs NVST · P/E 17, rev $628.7M vs P/E 56, rev $1.44B
Exelixis Inc (EXEL) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the EXEL and NVST stock pages for the full models.
Not investment advice.